NewsRx

Search our medical news database

Biological Warfare

ABS Negotiates Anthrax And Smallpox Vaccine Agreement

Published in Medical Letter on the CDC and FDA, December 23rd, 2001

American Biogenetic Sciences, Inc., (MABA, ABS) has negotiated a 10-year agreement with the Ministry of Health of the Russian Federation covering human vaccines for anthrax, smallpox, botulism and other diseases. A second agreement with the Russian Agricultural Academy extends ABS' rights for livestock vaccines, including one for animal anthrax.

The agreements govern vaccine distribution to specified global territories including North America, South America, the European Community, and the Pacific Rim.

"This is a very significant partnership given recent events in the United States and the imminent and real threat of bioterrorism," said ABS...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook